UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008690
Receipt number R000010216
Scientific Title Efficacy of automated carbon dioxide insufflation and IV Buscopan as a muscle relaxant in computed tomography colonography.
Date of disclosure of the study information 2012/08/15
Last modified on 2014/12/27 10:20:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of automated carbon dioxide insufflation and IV Buscopan as a muscle relaxant in computed tomography colonography.

Acronym

Efficacy of automated CO2 insufflation and IV Buscopan in CT colonography

Scientific Title

Efficacy of automated carbon dioxide insufflation and IV Buscopan as a muscle relaxant in computed tomography colonography.

Scientific Title:Acronym

Efficacy of automated CO2 insufflation and IV Buscopan in CT colonography

Region

Japan


Condition

Condition

Healthy individual

Classification by specialty

Gastroenterology Radiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluation of efficacy of automated carbon dioxide insufflation and IV Buscopan as a muscle relaxant in computed tomography colonography

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Assessment of colon and small intestine distension per segment using a 4-point scale (prone and supine).

Key secondary outcomes

Data on perceived burden of CT colonography were collected using visual analogue scale (VAS) and a questionnaire.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

4

Purpose of intervention

Diagnosis

Type of intervention

Medicine Device,equipment

Interventions/Control_1

Automated carbon dioxide insufflation with intravenous injection of butyl scopolamine (Buscopan)

Interventions/Control_2

Manual carbon dioxide insufflation without butyl scopolamine (Buscopan)

Interventions/Control_3

Manual carbon dioxide insufflation with intravenous injection of butyl scopolamine (Buscopan)

Interventions/Control_4

Automated carbon dioxide insufflation without butyl scopolamine (Buscopan)

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Healthy individual.
2) Major functions of organs of the subjects are in a good condition.
3) Aged 40 years or older.
4) Signed informed consent forms are obtained by the patients.

Key exclusion criteria

1) Patients with inflammatory bowel disease.
2) Fulfillment of clinical criteria for diagnosis of FAP or HNPCC (Amsterdam criteria).
3) Contraindication for using Buscopan.
4) Previous colorectal surgery.
5) Gastric or intestinal stenosis, abdominal adhesions, bowel obstruction or perforation, toxic megacolon.
6) Evidence of an increased risk in carrying out bowel preparation or CTC exams.
7) Possibility of pregnancy.
8) Patients with psychological conditions that contraindicate colonoscopy or make them irrelevant to participate in the trial.
9) Claustrophobia.
10) Severe deafness.
11) Subjects whose eligibility for this clinical trial is not appropriate by other reasons.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Koichi Nagata M.D PhD

Organization

Kameda Medical Center Makuhari

Division name

Department of Gastroenterology

Zip code


Address

1-3 CD2, Nakase, Mihama-ku, Chiba, 261-8501, Japan

TEL

043-296-2711

Email

Nagata7@aol.com


Public contact

Name of contact person

1st name
Middle name
Last name Koichi Nagata M.D PhD

Organization

Kameda Medical Center Makuhari

Division name

Department of Gastroenterology

Zip code


Address

1-3 CD2, Nakase, Mihama-ku, Chiba, 261-8501, Japan

TEL

043-296-2711

Homepage URL


Email

Nagata7@aol.com


Sponsor or person

Institute

Kameda Medical Center Makuhari

Institute

Department

Personal name



Funding Source

Organization

Kameda Medical Center Makuhari

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

None

Name of secondary funder(s)

EIDIA Co., Ltd.


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

亀田メディカルセンター幕張(千葉県)


Other administrative information

Date of disclosure of the study information

2012 Year 08 Month 15 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

http://www.ajronline.org/doi/abs/10.2214/AJR.14.12772

Number of participants that the trial has enrolled


Results

OBJECTIVE
The purpose of this article is to evaluate the efficacy of IV hyoscine butylbromide as a bowel relaxant and automated carbon dioxide insufflation in CT colonography in terms of colonic distention and perceived burden.
SUBJECTS AND METHODS
Two hundred twenty-four participants were randomly allocated to one of four groups: control (no bowel relaxant and IV saline placebo before CT colonography with manual carbon dioxide insufflation), hyoscine butylbromide (IV hyoscine butylbromide before examination with manual carbon dioxide insufflation), automated (no bowel relaxant before examination with automated carbon dioxide insufflation), and combined (hyoscine butylbromide before examination with automated carbon dioxide insufflation). The degree of colonic distention on a 4-point scale, examination time, and participants' satisfaction, as measured by their responses to a questionnaire, were assessed.
RESULTS
The mean distention grades of all the colonic segments and both positions were 3.22 in the control group, 3.28 in the hyoscine butylbromide group, 3.77 in the automated group, and 3.74 in the combined group. Compared with manual carbon dioxide insufflation, automated carbon dioxide insufflation significantly improved the clinical adequacy of colonic distention and shortened examination time. No statistically significant difference was seen in the clinical adequacy of distention between participants who received hyoscine butylbromide and those who did not, or in examination time. Overall, the participants' experiences were not different.
CONCLUSION
Colonic distention was statistically significantly improved by automated carbon dioxide insufflation, but not by the administration of hyoscine butylbromide. The participants' tolerance was similar in each group.

Read More: http://www.ajronline.org/doi/abs/10.2214/AJR.14.12772

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2012 Year 06 Month 01 Day

Date of IRB


Anticipated trial start date

2012 Year 07 Month 01 Day

Last follow-up date

2013 Year 12 Month 31 Day

Date of closure to data entry

2014 Year 01 Month 31 Day

Date trial data considered complete

2014 Year 02 Month 28 Day

Date analysis concluded

2014 Year 06 Month 30 Day


Other

Other related information



Management information

Registered date

2012 Year 08 Month 15 Day

Last modified on

2014 Year 12 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010216


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name